Study Intelligence · PANC-301
Site feasibility and retention evidence for Phase III Pancreatic Cancer Study.
Phase III · Pancreatic adenocarcinoma · United States · recruitment target 420 subjects. Ask a feasibility question below; the answer arrives with its sources, its decision path, and the analysis behind it.
Feasibility question
Ask about sites, patient potential, or retention risk. The answer arrives with its sources and decision path.
Guided analysis
Analysis breakdown
How 312 sites were narrowed to 6 for PANC-301
Each row is a subset of the row above. Bar width is the share of all sites searched.
Sites retained at the stage Recommended for further feasibility assessmentCounts are sites; percentages show what was retained from the previous stage and from the 312 searched.